MOUNT PEARL, NEWFOUNDLAND AND LABRADOR , CANADA, December 30, 2025 /EINPresswire.com/ — Steve Kent, elected in August 2024 to the World Scout Committee — the governing body of the World Organization ...
Abstract: This article proposes a fast and effective method to analyze the scattering characteristics of large array structures based on the infinitesimal dipole model (IDM). Different from the ...
Abstract: This paper investigates and implements a miniaturized microwave system for microstrip linear array antenna that operates in X-band (10.1 GHz), S-band (3.4 GHz) and C-band (5.6 GHz). The ...
Structure Therapeutics Inc. earns a Strong Buy rating following robust phase 2b data for oral GLP-1R agonist Aleniglipron in obesity. Aleniglipron achieved placebo-adjusted weight loss up to -15.3% at ...
Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related treatment discontinuation Placebo-adjusted mean weight ...
SAN FRANCISCO, Dec. 07, 2025 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (GPCR), a clinical-stage global biopharmaceutical company developing novel oral small molecule therapeutics for metabolic ...